These two cases provide evidence-based clinical pearls for managing influenza in the pediatric population, with an emphasis on identification of children at high risk of influenza complications, influenza testing, timing of treatment, and dosing of recommended antivirals.
When is a nosebleed not a normal nosebleed? How much menstrual bleeding is too much? Hemophilia is the best-known bleeding disorder and perhaps the most severe, but there are other milder diseases like von Willebrand disease that are much more common. What are the common myths and perceptions about children with disorders of coagulation? What does the general pediatrician need to know about bleeding disorders? The speaker will cover the basics of identifying children with abnormal bleeding and managing their conditions effectively.
In the United States, over six million children have asthma and over 130,000 children are hospitalized yearly due to asthma exacerbations. Children with difficult-to-treat and/or severe asthma have the highest morbidity and mortality. In addition to ensuring assessment and management per existing guidelines, there is a need for more precise and personalized approaches to asthma management for these patients. This includes identification of phenotypes and tailoring medication choice based on underlying pathophysiology. This talk will address the fundamentals of identifying difficult-to-treat and severe asthma patients and outline steps to create a comprehensive asthma assessment and management plan.
Attention deficit/hyperactivity disorder is a common condition in children and adolescents, requiring careful diagnosis and targeted treatment. In this session, learn how to identify the core symptoms of ADHD; how to select and sequence stimulant and non-stimulant medication, based on symptom presentation; and when psychosocial interventions are appropriate.
In this lecture, Dr. Wurm will review recent studies on nutrition and integrative pediatrics including ones on dietary interventions, exercise programs and meditation. Effective strategies to implement these into practice to reduce pediatric obesity will be discussed.
Dr. Chris Giza, Director of the UCLA Steve Tisch BrainSPORT Program and a Professor of Pediatric Neurology at UCLA will review evidence-based management for youth sports concussion. He will discuss epidemiology of sports concussions in children, diagnosis, and recommended management including recent updates in the field of concussion management in young children. He will also review the current evidence for controversies in concussion including second impact syndrome, cognitive rest and chronic neurocognitive impairment.
Get the latest updates on the new clinical practice guidelines for food allergies management by the NIAID. Learn about the definition of food allergy and how to differentiate between allergy and intolerance. The faculty will also discuss the management of acute and non-acute allergic reactions and review prevention strategies.
In this activity, Dr. Katz will discuss common endocrine disrupting chemicals found in plastics today and their effect on health. He will also outline strategies to limit exposure and mention steps, both physicians and patients can take to increase awareness about the long-term health effects of EDCs.
Obesity in childhood is associated with multiple comorbidities and one out of every 3 children is classified as obese or overweight by their 5th birthday. This program will review the epidemiology and etiology of obesity in childhood. Participants will be able to discuss behaviors within the family that can reduce the risk of obesity as well as discuss community based strategies for childhood obesity.
ADHD is a rising concern in children and adolescents. In this activity, learn about effectively treating ADHD in the presence of comorbid conditions such as depression and anxiety disorders. Dr. Cummins also explains management strategies for dealing with side effects normally associated with stimulants prescribed for ADHD.
This program aims to discuss the endocrine morbidity issues associated with obese children. This program will also discuss methods for screening for these metabolic complications and develop treatment plans for these complications.
In this activity will provide an overview of inflammatory bowel disease in children. Dr. Strople will review the pathogenesis of the disease and highlight the differentiating points between adult and pediatric IBD disease. Pathophysiology of crohn's disease and ulcerative colitis in children will also be discussed along with treatment and management strategies.